Firms

CTI Life Sciences Fund

CTI Life Sciences Fund is a Montreal-based life-sciences venture capital firm and biotechnology company builder. It finances therapeutic assets and platforms from company formation through clinical development, supporting scientific validation, management, financing and eventual exits. The firm invests across therapeutic areas and drug modalities; its portfolio includes neuroscience-related programs at Aeovian Pharmaceuticals and Find Therapeutics, AI-enabled drug discovery at Phenomic AI, and rare-disease substrate replacement therapies at Glycomine. CTI operates a succession of investment funds and works with academic, pharmaceutical and biotechnology partners to create companies around promising research.

Founded: 2006
Type: Venture capital